On Monday, April 8, at 10 am Central Time, VBDCC Design & Analysis Unit director Matt Shotwell will participate in the Institute for Global Health's Grand Rounds on the work of the ACTIV-4 Host Tissue platform trial. The online event will be held on Teams.
